EPISODE · Jan 5, 2026 · 5 MIN
EP 084.全球医药资助合规与数字化转型：从“阿斯利康案”到 AI 风险防控
from MedVerse医路人
在医药资助领域，合规不仅是企业的护城河，更是生存底线。随着全球监管手段的数字化，企业如何平衡“激励政策利用”与“合规风险防控”？本期带来系统性解答：🗝️ 核心干货： 国际政策对比 合规案例深挖 数字化转型实践 AI 风险评估 2025 全球新趋势资助的本质是推动科学进步，而合规工具的升级则是为了让这一过程更加透明高效。关于节目《MedVerse 医路人》是一档聚焦医药行业职业发展、市场与学术推广、以及行业趋势观察的播客。我们希望通过行业解析、案例分享与对话讨论，帮医药人看清职场成长的底层逻辑，找到更清晰的发展路径。找到我们公众号：达维思MedVerse小红书：达利Dali视频号：达维思MedVerse收听渠道：小宇宙、喜马拉雅、苹果Podcast*扣子空间前往小宇宙评论区与主播互动
Embed this episode
Ready to play
EP 084.全球医药资助合规与数字化转型：从“阿斯利康案”到 AI 风险防控
0:00
5:45
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of MedVerse医路人?
This episode is 5 minutes long.
When was this MedVerse医路人 episode published?
This episode was published on January 5, 2026.
Can I download this MedVerse医路人 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!